Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.841
-0.021 (-2.46%)
Nov 21, 2024, 3:47 PM EST - Market open

Carisma Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-63.8-86.88-61.23-40.78-28.35
Depreciation & Amortization
3.412.841.890.680.45
Other Amortization
-1.282.54--
Loss (Gain) From Sale of Assets
0.080.16---
Loss (Gain) From Sale of Investments
-0.37-1.11---
Stock-Based Compensation
3.672.320.280.480.16
Other Operating Activities
7.155.656.210.831.18
Change in Accounts Payable
-0.412.19-0.47-0.971.28
Change in Unearned Revenue
-4.25-1.0547.46--
Change in Other Net Operating Assets
-13.21-6.58-1.792.44-1.74
Operating Cash Flow
-67.66-81.18-5.12-37.33-27.01
Capital Expenditures
-0.68-1.13-4.66-1.87-0.44
Investment in Securities
1173.54-27.9--
Investing Cash Flow
10.3272.41-32.56-1.87-0.44
Long-Term Debt Issued
-1.1836.63--
Long-Term Debt Repaid
--2.37-0.96--
Net Debt Issued (Repaid)
-2.05-1.1935.66--
Issuance of Common Stock
3.1131.420.11-0.02
Other Financing Activities
-31.94-2.45-0.37-
Financing Cash Flow
1.0762.1833.3215.9672.26
Net Cash Flow
-56.2853.41-4.36-23.2444.81
Free Cash Flow
-68.35-82.31-9.78-39.2-27.45
Free Cash Flow Margin
-337.21%-551.71%-99.41%--
Free Cash Flow Per Share
-1.66-2.46-4.59-36.16-25.82
Cash Interest Paid
0.220.350.1--
Levered Free Cash Flow
-41.39-51.52-30.1-24.24-
Unlevered Free Cash Flow
-41.39-52.8-30.68-24.24-
Change in Net Working Capital
6.051.37-6.92-1.97-
Source: S&P Capital IQ. Standard template. Financial Sources.